
PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease
31 Jul 2019

EORTC and ESTRO announce a new collaboration to maximise the benefits of radiation oncology
23 Apr 2018

EORTC at ESTRO37 Congress
19 Apr 2018

Interim Results of the CATNON Study – the Effects of Temozolomide
31 Aug 2017

EORTC hosting session at ICTR-PHE 2016 in Geneva
9 Dec 2015

20-year follow-up of the academic EORTC boost no-boost trial earns Best Abstract at ECC 2015
14 Sep 2015

Can abiraterone and radiotherapy improve survival for patients with metastatic prostate cancer treated with ADT?
10 Feb 2015

EORTC launches LungTech
27 Jan 2015